total cryptocurrency in the world Top Featured

Agency: It is expected that the shipment of folding smartphones will continue to decline in 2025. According to the latest report of Counterpoint Research, the year-on-year shipment of folding smartphone displays declined for the first time in the third quarter of 2024, and it is expected that the shipment in 2025 will also continue to decline. The agency expects Apple to enter the market in the second half of 2026. In addition, more multi-fold products are expected to be launched in 2026, and the first slidable notebook computer is expected to be available in 2025.Agency: It is expected that the shipment of folding smartphones will continue to decline in 2025. According to the latest report of Counterpoint Research, the year-on-year shipment of folding smartphone displays declined for the first time in the third quarter of 2024, and it is expected that the shipment in 2025 will also continue to decline. The agency expects Apple to enter the market in the second half of 2026. In addition, more multi-fold products are expected to be launched in 2026, and the first slidable notebook computer is expected to be available in 2025.Agency: It is expected that the shipment of folding smartphones will continue to decline in 2025. According to the latest report of Counterpoint Research, the year-on-year shipment of folding smartphone displays declined for the first time in the third quarter of 2024, and it is expected that the shipment in 2025 will also continue to decline. The agency expects Apple to enter the market in the second half of 2026. In addition, more multi-fold products are expected to be launched in 2026, and the first slidable notebook computer is expected to be available in 2025.

Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.The United Nations appealed for $4 billion in aid to Palestine. On December 11th, local time, the United Nations appealed for more than $4 billion in aid to the Gaza Strip and the West Bank in 2025 to meet the living needs of local people. On the same day, the United Nations Office for the Coordination of Humanitarian Affairs said that due to Israel's restrictions on the transportation of local humanitarian relief materials, the Office for the Coordination of Humanitarian Affairs could only reduce the amount of assistance to about 4 billion US dollars, while the actual amount of assistance needed locally may be higher, at least 6.6 billion US dollars.The resumption of trading of Hong Kong stocks Xinwei International soared by over 80%. In the news, Zhan Peizhong, the controlling shareholder, was convicted, which did not affect the takeover offer of Fuheng Group.

The main fuel oil contract rose by more than 3%, and it is now reported at 3158 yuan/ton.Musk: Nothing is more beneficial to American health than "ultra-low-cost" diet pills. Musk advocates the use of diet pills to reduce American medical expenses. On December 11th, local time, Musk posted on social platform X that nothing can improve the health, longevity and quality of life of Americans better than very cheap GLP-1 drugs. He pointed out that most medical expenses occur at the end of life, and obesity is often an important factor leading to diseases. Therefore, popularizing GLP-1 drugs can save medical expenses on a long-term scale.Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.